Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells

Neuroscience

Volumn 165, Issue 4, 2010, Pages 1312-1322

  Gessler, F ^a   Voss, V ^a   Dutzmann S ^a   Seifert, V ^a   Gerlach, R ^a   Kogel D ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

blood coagulation cascade; cell invasion; cell migration; MAP kinase; tumor hypoxia

Indexed keywords

BLOOD CLOTTING FACTOR 7A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEINASE ACTIVATED RECEPTOR 2; THROMBOPLASTIN;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER INVASION; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MACROGLIA; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; GLIOMA; HUMANS; LENTIVIRUS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; RECEPTOR, PAR-2; RNA INTERFERENCE; THROMBOPLASTIN;

EID: 73749085142     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.11.049     Document Type: Article

References (37)

1. Ahamed J., Versteeg H.H., Kerver M., Chen V.M., Mueller B.M., Hogg P.J., and Ruf W. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A 103 (2006) 13932-13937
2. Amirkhosravi A., Meyer T., Warnes G., Amaya M., Malik Z., Biggerstaff J.P., Siddiqui F.A., Sherman P., and Francis J.L. Pentoxifylline inhibits hypoxia-induced upregulation of tumor cell tissue factor and vascular endothelial growth factor. Thromb Haemost 80 (1998) 598-602
3. Beavon I.R. Regulation of E-cadherin: does hypoxia initiate the metastatic cascade?. Mol Pathol 52 (1999) 179-188
4. Belting M., Ahamed J., and Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol 25 (2005) 1545-1550
5. Brat D.J., and Van Meir E.G. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 84 (2004) 397-405
6. Callander N.S., Varki N., and Rao L.V. Immunohistochemical identification of tissue factor in solid tumors. Cancer 70 (1992) 1194-1201
7. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
8. Dorfleutner A., Hintermann E., Tarui T., Takada Y., and Ruf W. Cross-talk of integrin alpha3beta1 and tissue factor in cell migration. Mol Biol Cell 15 (2004) 4416-4425
9. Eckerich C., Zapf S., Fillbrandt R., Loges S., Westphal M., and Lamszus K. Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration. Int J Cancer 121 (2007) 276-283
10. Evans S.M., Judy K.D., Dunphy I., Jenkins W.T., Hwang W.T., Nelson P.T., Lustig R.A., Jenkins K., Magarelli D.P., Hahn S.M., Collins R.A., Grady M.S., and Koch C.J. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 10 (2004) 8177-8184
11. Hamada K., Kuratsu J., Saitoh Y., Takeshima H., Nishi T., and Ushio Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 77 (1996) 1877-1883
12. Hetschko H., Voss V., Horn S., Seifert V., Prehn J.H., and Kögel D. Pharmacological inhibition of Bcl-2 family members reactivates TRAIL-induced apoptosis in malignant glioma. J Neuro Oncol 86 (2008) 265-272
13. Hoelzinger D.B., Demuth T., and Berens M.E. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99 (2007) 1583-1593
14. Hua Y., Tang L., Keep R.F., Schallert T., Fewel M.E., Muraszko K.M., Hoff J.T., and Xi G. The role of thrombin in gliomas. J Thromb Haemost 3 (2005) 1917-1923
15. Huang C., Jacobson K., and Schaller M.D. MAP kinases and cell migration. J Cell Sci 117 (2004) 4619-4628
16. Kim J.Y., Kim Y.J., Lee S., and Park J.H. The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells. BMC Cancer 9 (2009) 27
17. Kleihues P., Louis D.N., Scheithauer B.W., Rorke L.B., Reifenberger G., Burger P.C., and Cavenee W.K. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61 (2002) 215-225 discussion 226-219
18. Lakka S.S., Rajan M., Gondi C., Yanamandra N., Chandrasekar N., Jasti S.L., Adachi Y., Siddique K., Gujrati M., Olivero W., Dinh D.H., Kouraklis G., Kyritsis A.P., and Rao J.S. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene 21 (2002) 8011-8019
19. Le Mercier M., Fortin S., Mathieu V., Roland I., Spiegl-Kreinecker S., Haibe-Kains B., Bontempi G., Decaestecker C., Berger W., Lefranc F., and Kiss R. Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. Neoplasia 11 (2009) 485-496 (New York, NY)
20. Lefranc F., Brotchi J., and Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23 (2005) 2411-2422
21. Milsom C.C., Yu J.L., Mackman N., Micallef J., Anderson G.M., Guha A., and Rak J.W. Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Res 68 (2008) 10068-10076
22. Monroe D.M., and Key N.S. The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking. J Thromb Haemost 5 (2007) 1097-1105
23. Ogiichi T., Hirashima Y., Nakamura S., Endo S., Kurimoto M., and Takaku A. Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation. J Neurooncol 46 (2000) 1-9
24. Phillips H.S., Kharbanda S., Chen R., Forrest W.F., Soriano R.H., Wu T.D., Misra A., Nigro J.M., Colman H., Soroceanu L., Williams P.M., Modrusan Z., Feuerstein B.G., and Aldape K. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9 (2006) 157-173
25. Postovit L.M., Adams M.A., Lash G.E., Heaton J.P., and Graham C.H. Oxygen-mediated regulation of tumor cell invasiveness. Involvement of a nitric oxide signaling pathway. J Biol Chem 277 (2002) 35730-35737
26. Rong Y., Belozerov V.E., Tucker-Burden C., Chen G., Durden D.L., Olson J.J., Van Meir E.G., Mackman N., and Brat D.J. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. Cancer Res 69 (2009) 2540-2549
27. Rong Y., Durden D.L., Van Meir E.G., and Brat D.J. "Pseudopalisading" necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 65 (2006) 529-539
28. Rong Y., Hu F., Huang R., Mackman N., Horowitz J.M., Jensen R.L., Durden D.L., Van Meir E.G., and Brat D.J. Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res 66 (2006) 7067-7074
29. Rong Y., Post D.E., Pieper R.O., Durden D.L., Van Meir E.G., and Brat D.J. PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res 65 (2005) 1406-1413
30. Ruf W. Tissue factor and PAR signaling in tumor progression. Thromb Res 120 Suppl 2 (2007) S7-S12
31. Schaffner F., and Ruf W. Tissue factor and protease-activated receptor signaling in cancer. Semin Thromb Hemost 34 (2008) 147-153
32. Shikamoto Y., and Morita T. Expression of factor X in both the rat brain and cells of the central nervous system. FEBS Lett 463 (1999) 387-389
33. Shimamoto R., Sawada T., Uchima Y., Inoue M., Kimura K., Yamashita Y., Yamada N., Nishihara T., Ohira M., and Hirakawa K. A role for protease-activated receptor-2 in pancreatic cancer cell proliferation. Int J Oncol 24 (2004) 1401-1406
34. Silver I., and Erecinska M. Oxygen and ion concentrations in normoxic and hypoxic brain cells. Adv Exp Med Biol 454 (1998) 7-16
35. Sullivan R., and Graham C.H. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 26 (2007) 319-331
36. Uusitalo-Jarvinen H., Kurokawa T., Mueller B.M., Andrade-Gordon P., Friedlander M., and Ruf W. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis. Arterioscler Thromb Vasc Biol 27 (2007) 1456-1462
37. Versteeg H.H., Schaffner F., Kerver M., Petersen H.H., Ahamed J., Felding-Habermann B., Takada Y., Mueller B.M., and Ruf W. Inhibition of tissue factor signaling suppresses tumor growth. Blood 111 (2008) 190-199